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Abstract
Background:  Chronic right ventricular apical pacing may have detrimental effect on left
ventricular function and may promote to heart failure in adult patients with left ventricular
dysfunction.
Methods: A group of 99 pediatric patients with previously implanted pacemaker was studied
retrospectively. Forty-three patients (21 males) had isolated congenital complete or advanced
atrioventricular block. The remaining 56 patients (34 males) had pacing indication in the presence
of structural heart disease. Thirty-two of them (21 males) had isolated structural heart disease and
the remaining 24 (13 males) had complex congenital heart disease. Patients were followed up for
an average of 53 ± 41.4 months with 12-lead electrocardiogram and transthoracic
echocardiography. Left ventricular shortening fraction was used as a marker of ventricular function.
QRS duration was assessed using leads V5 or II on standard 12-lead electrocardiogram.
Results:  Left ventricular shortening fraction did not change significantly after pacemaker
implantation compared to preimplant values overall and in subgroups. In patients with complex
congenital heart malformations shortening fraction decreased significantly during the follow up
period. (0.45 ± 0.07 vs 0.35 ± 0.06, p = 0.015). The correlation between the change in left
ventricular shortening fraction and the mean increase of paced QRS duration was not significant.
Six patients developed dilated cardiomyopathy, which was diagnosed 2 months to 9 years after
pacemaker implantation.
Conclusion: Chronic right ventricular pacing in pediatric patients with or without structural heart
disease does not necessarily result in decline of left ventricular function. In patients with complex
congenital heart malformations left ventricular shortening fraction shows significant decrease.
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Background
Chronic right ventricular (RV) apical pacing alters unfavo-
rably left ventricular (LV) electrical activation, mechanical
contraction, cardiac output, myocardial perfusion and
histology. Permanent RV pacing may have detrimental
effect on LV function and may promote to heart failure in
adult patients with LV dysfunction [1-10]. The effect of
chronic RV apical pacing on LV performance in pediatric
patients, although increasingly reported, is not fully inves-
tigated yet. Data about this are controversial [5,8,11,12].
Also, although congenital atrioventricular (AV) block
quite often is associated with other congenital heart dis-
eases [13-15], studies were mostly focused on patients
with isolated congenital AV block [8-16]. The aim of this
retrospective study was to assess the evolution of LV func-
tion in a mixed pediatric pacemaker population with and
without structural heart disease.
Methods
Study population
A group of 99 pediatric patients (55 males) was studied.
Forty-three patients (21 males) had isolated complete or
advanced AV block with severe bradycardia/pauses, syn-
cope, LV dilation or QT interval prolongation. The
remaining 56 patients had pacing indication and associ-
ated structural heart disease: 23 of them (13 males) had
complex congenital heart disease and the remaining 33
(21 males) had isolated structural heart disease (Table 1).
The pacing indication in the latter 2 groups was postoper-
ative AV block in 28 patients, congenital AV block in 14
patients, sinus node disease in 10 patients, LV outflow
tract obstruction relief in 2 patients, and prolonged QT
interval with syncope in 2 patients.
All patients had single chamber (right ventricle) or dual
chamber (right atrium, right ventricle) systems implanted.
Patients with dual-chamber systems pacing only the
atrium as well as patients having less than 80% RV pacing
(assessed by pacemaker diagnostics) were excluded from
the study. Patients were followed up with transthoracic
echocardiography and 12-lead electrocardiogram. QRS
duration measurements were performed on electrocardio-
gram with recording speed of 50 mm/sec or 25 mm/sec in
lead V5 or lead II. Left ventricular shortening fraction
defined as: (end-diastolic diameter – end-systolic diame-
ter)/end-diastolic diameter, was used as a marker of LV
function. Data on LV function were analyzed in six pedi-
atric age groups (<1 yr; 1–2 yrs; 3–4 yrs; 5–7 yrs; 8–11 yrs
and 12–15 yrs).
Comparisons were performed between the last LV short-
ening fraction value before pacemaker implantation and
the LV shortening fraction value at last follow-up after
pacemaker implantation, in the whole group and within
the 3 subgroups of patients. Comparison was also made
throughout the follow up from LV shortening fraction in
age groups. Correlation analysis was performed between
the mean change of LV shortening fraction and the mean
increase of QRS duration before and after pacemaker
implantation.
Statistical analysis
Data are presented as mean ± standard deviation. Statisti-
cal analysis was performed using paired and independent
samples T-test, and Spearman's ρ correlation. P < 0.05 was
considered significant.
Results
Overall patients were followed up for an average of 53 ±
41.4 months (range 0.5–188.5 months). The mean age at
pacemaker implantation in isolated AV block subgroup
was 44.1 ± 48 months with a median of 29 months (range
0–139.25). Almost half of those patients had their pace-
maker implanted during the first year of life. Patients in
this subgroup were followed-up on average for 50.2 ±
42.2 months (range 0.5–188.5).
The mean age at pacemaker implantation in complex con-
genital heart disease subgroup was 45.4 ± 39.8 months
Table 1: Isolated structural heart disease and complex congenital 
heart disease
Isolated structural heart disease/ISHD 33
TGA 5
AVSD 5
ASD 2
AoI 3
ToF 5
PDA 2
VSD + PFO 3
VSD 2
CoAo 3
Sick sinus syndrome + bifurcational pulmonary stenosis 3
Complex congenital heart disease/CCHD 23
VSD, ASD, pulmonary atresia 3
CoAo, VSD, PDA 3
VSD, ASD, TGA, PDA 5
VSD, TGA 4
VSD, PDA, PFO 1
VSD, DORV, PS 2
VSD, DORV, TGA 2
TGA, PS 2
VSD, PDA, pulmonary atresia 1
TGA – transposition of the great arteries; AVSD – atrioventricular 
septal defect; ASD – atrial septal defect; AoI – aortic insufficiency; ToF 
– tetralogy of Fallot; PDA – patent ductus arteriosus; VSD – 
ventricular septal defect; PFO – persistent foramen ovale; CoAo – 
Aortic coarctation; DORV – double outlet right ventricle; PS – 
pulmonary stenosis; HOCM – hypertrophic obstructive 
cardiomyopathy; ARVD – arrhythmogenic right ventricular dysplasia.Cardiovascular Ultrasound 2007, 5:13 http://www.cardiovascularultrasound.com/content/5/1/13
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with a median of 38.4 months (range 0–173). The mean
follow-up in this subgroup was 58.1 ± 42.2 months (range
3–168). Two patients with complex congenital heart dis-
ease died during the follow-up from sudden cardiac
death.
The mean age at pacemaker implantation in isolated
structural heart disease subgroup was 60.1 ± 53.5 months
with a median of 48.6 months (range 0–163). The mean
follow-up in this subgroup was 52.8 ± 40.7 months (range
3–152). One patient in this subgroup died during the fol-
low-up from intractable end-stage heart failure.
Neither the mean age at pacemaker implantation nor the
mean duration of the follow-up showed significant differ-
ence between the subgroups of patients (p = NS). The
mean LV shortening fraction did not change significantly
at last follow-up after pacemaker implantation compared
to last preimplant values overall and in the subgroups
(Table 2 and figure 1).
When analysis was performed throughout the age groups,
the change of mean LV shortening fraction was not signif-
icant overall and in the subgroups with isolated complete
AV block and isolated structural heart disease. However,
in the subgroup with complex congenital heart disease a
significant decrease of mean LV shortening fraction was
observed (patients aged <1 year: 0.45 ± 0.07 versus
patients aged 12–15 years: 0.35 ± 0.06, p = 0.015) (Table
3).
The correlation between the mean change of LV shorten-
ing fraction after pacemaker implantation and the mean
increase of paced QRS duration was not significant (Table
4).
The correlation between the mean change of LV shorten-
ing fraction after pacemaker implantation and the pacing
duration was not significant as well. This was true for the
overall group and for the subgroups as well. The two
extremes for Spearman's rho coefficient in this correlation
were -0.209 and 0.22 with a non-significant P value.
Five patients with isolated complete AV block and 1
patient (all males) with ostium secundum type atrial sep-
tal defect developed dilated cardiomyopathy during the
follow-up. Two of them were anti-Ro/SS-A positive (both
with isolated complete AV block). The remaining four
were not studied for presence of antibodies. All patients
with isolated complete AV block had pacemaker
implanted at birth, the remaining patient at the age of
20.5 months. Left ventricular shortening fraction was
slightly depressed at the time of pacemaker implantation
in 2 patients with complete AV block. Dilated cardiomy-
opathy was diagnosed 2 to 24 months after pacemaker
implantation in all patients with isolated complete AV
block and 9 years after pacemaker implantation in the
patient with atrial septal defect.
Discussion
The main finding of this study is that RV apical pacing in
children with or without structural heart disease during a
mid-term follow-up does not cause significant decrease in
LV function as represented by the shortening fraction.
Data from trials with adult patients raised concerns about
the negative effect of RV apical pacing on LV function
[2,3,6,7,9,10]. Due to longer periods of pacing starting
not infrequently immediately after birth, these concerns
seem to be even more warranting in pediatric patients.
Data about the long-term effect of RV apical pacing in
children and adolescents are still controversial, some
studies supporting the same negative impact observed in
adults [4,5,8], while other show opposite results [12]. The
present study did not find any significant decrease of LV
shortening fraction in this mixed pediatric population
and in the subgroups with isolated complete AV block and
isolated structural heart disease. However, we were able to
find a statistically significant decline in LV function in the
Table 2: Evolution of left ventricular shortening fraction
Last LV SF before PMI LV SF at last follow-up p
Overall 0.41 ± 0.09 0.39 ± 0.11 NS
ICAVB 0.40 ± 0.07 0.37 ± 0.09 NS
CCHD 0.43 ± 0.10 0.39 ± 0.09 NS
ISHD 0.40 ± 0.11 0.41 ± 0.15 NS
CCHD – patients with complex congenital heart disease
ICAVB – patients with isolated congenital complete or advanced AV block
ISHD – patients with isolated structural heart disease
LV SF – left ventricular shortening fraction
NS – not significant
PMI – pacemaker implantationCardiovascular Ultrasound 2007, 5:13 http://www.cardiovascularultrasound.com/content/5/1/13
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Table 3: Evolution of left ventricular shortening fraction throughout the age groups.
LV SF in pts < 1 year LV SF in pts 12–15 yrs p
Overall 0.43 ± 0.09 0.4 ± 0.12 NS
ICAVB 0.39 ± 0.08 0.41 ± 0.07 NS
CCHD 0.45 ± 0.07 0.35 ± 0.06 0.015
ISHD 0.49 ± 0.08 0.42 ± 0.18 NS
CCHD – patients with complex congenital heart disease
ICAVB – patients with isolated congenital complete or advanced AV block
ISHD – patients with isolated structural heart disease
LV SF – left ventricular shortening fraction
NS – not significant
Left ventricular fractional shortening (LV FS) before PM  implantation (LV FS 1) and at last follow up (LV FS 2) Figure 1
Left ventricular fractional shortening (LV FS) before PM 
implantation (LV FS 1) and at last follow up (LV FS 2).
0,39 0,41
0
0,1
0,2
0,3
0,4
0,5
0,6
LV SF1 LV SF2
Table 4: Spearman's rho correlation between ∆LV SF and increase of paced vs intrinsic QRS duration.
Mean ∆LV SF (%) Mean ∆QRS (ms) ρ p
Overall -0.01 ± 0.12 65.9 ± 25.6 -0.175 NS
ICAVB -0.02 ± 0.1 71.4 ± 21.6 -0.006 NS
CCHD -0.04 ± 0.12 54.2 ± 30.2 -0.08 NS
ISHD 0.01 ± 0.15 65 ± 26 -0.349 NS
∆LV SF – change of left ventricular shortening fraction
∆QRS – change of paced QRS duration after pacemaker implantation vs intrinsic
QRS duration before pacemaker implantation
CCHD – patients with complex congenital heart disease
ICAVB – patients with isolated congenital complete or advanced AV block
ISHD – patients with isolated structural heart disease
NS – not significantCardiovascular Ultrasound 2007, 5:13 http://www.cardiovascularultrasound.com/content/5/1/13
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subgroup of patients with complex congenital heart dis-
ease.
Only approximately a quarter of the patients with struc-
tural heart disease had their pacemaker implanted during
the first year of life compared to almost half of the patients
with isolated complete AV block. This shift of the median
age of pacemaker implantation in patients with structural
heart disease compared to isolated complete AV block
subgroup reflects mainly the time of palliative or totally
corrective surgery for congenital heart disease, which fre-
quently causes conduction disturbances necessitating
pacemaker therapy.
In this study the mean increase of QRS duration in
patients with isolated complete AV block was greater than
in patients with structural heart disease. This was not due
to more pronounced effect of RV pacing on the QRS dura-
tion, but to narrower intrinsic QRS complex in patients
with isolated complete AV block compared to patients
with structural heart disease. We were not able to find any
significant correlation between the mean change of LV
shortening fraction and QRS in neither of age groups or in
the whole group.
Limitations of the study
The study is retrospective. The shortening fraction is prob-
ably not the best marker for systolic function, but it is the
most consistently measured in the study population.
Given the fact that segmental wall motion abnormalities
in children are extremely rare, one can assume that short-
ening fraction is reliable enough in this regard.
Conclusion
Chronic RV apical pacing in pediatric patients with or
without structural heart disease does not necessarily result
in decline of LV function. In pediatric patients with com-
plex congenital cardiac malformations a significant
decrease of LV shortening fraction was observed. The
mean change of LV shortening fraction after pacemaker
implantation is not related to the increase of paced QRS
duration. Progression to dilated cardiomyopathy after
pacemaker implantation is observed in 6% in this popu-
lation. It can develop late after pacemaker implantation.
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